Physician profile
Kyle A Ward
NPI 1831487222
$787.83
in general payments reported to CMS, 2019-2025
22 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $202 · 2021: $82.20 · 2022: $50.54 · 2023: $121 · 2024: $14.35 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $262.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $158.22 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $82.91 | 2019-2025 | Airsupra |
| Amarin Pharma, INC. | $54.70 | 2019-2020 | |
| Amgen INC. | $53.21 | 2019 | |
| Glaxosmithkline, LLC. | $52.24 | 2019-2020 | |
| Abbott Laboratories | $46.68 | 2022-2023 | Freestyle Libre 3 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $41.82 | 2025 | Caplyta |
| Abbvie INC. | $36.04 | 2023-2025 | Ubrelvy, Qulipta |
| Novartis Pharmaceuticals Corporation | $34.51 | 2020-2021 | |
| Pfizer INC. | $28.01 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.03 | 2021 | |
| Exact Sciences Corporation | $22.71 | 2023 | Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $18.48 | 2025 | Inspire |
| Esperion Therapeutics, INC. | $17.91 | 2020 | |
| Allergan, INC. | $17.29 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $16.67 | 2020 | |
| Daiichi Sankyo INC. | $15.74 | 2021 | |
| Genentech USA, INC. | $14.67 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.45 | 2023 | Xifaxan |
| Merck Sharp & Dohme LLC | $12.69 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.70 | 2019 | |
| Eisai INC. | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.